课题基金 / 基金详情

IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT

IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT
IGF::OT::IGF 核心基础设施支持
批准号：
9345565
负责人：
POWEL BROWN
金额：
$111.18万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
项目状态：
已结题
起止时间：
2015-09-24 至 2017-09-23
来源：
https://reporter.nih.gov/project-details/9345565
关键词：
ChemopreventionClinicalClinical TrialsConduct Clinical TrialsContractorDataDevelopmentDivision of Cancer PreventionDrug IndustryFundingGuidelinesIndividualMaintenanceMalignant NeoplasmsMolecular TargetMonitorNational Cancer InstituteOutcomePerformancePhasePreventionPreventiveProtocols documentationRequest for ProposalsResearch InfrastructureSafetySiteSpecific qualifier valueTimeVisitcancer preventionclinically relevantdata managementinterestlaboratory experimentmeetingsprevention clinical trialprogramsprotocol development

项目摘要

项目成果

POWEL BROWN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The National Cancer Institute (NCI), Division of Cancer Prevention (DCP) Phase 0/I/II Cancer Prevention Clinical Trials Program supports early clinical trials to rapidly evaluate the clinical activity and biologic effects of cancer preventive agents of interest to DCP. The agents to be studied shall include agents developed by the pharmaceutical industry and provided to DCP for collaborative development, commercially available agents, and agents developed by DCP. The objectives of this Task Order are to provide the core infrastructure to support the conduct of the clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-
TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION
TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data